Targeting BDCA2 suppresses Plasmacytoid dendritic cell dependent interferon response and tissue fibrosis
Ross, R. L.; Corinaldesi, C.; Migneco, G.; Carr, I.; Antanaviciute, A.; Carriero, A.; Wasson, C.; Georgiou, I.; Distler, J. H. W.; Holmes, S.; El-Sherbiny, Y. M.; McKimmie, C. S.; Del Galdo, F.
Show abstract
Plasmacytoid dendritic cells (pDC) have been implicated in the pathogenesis of Scleroderma (SSc) through their ability to infiltrate the skin and secrete interferons (IFN) and proinflammatory chemokines. Blood Dendritic Cells Antigen 2 (BDCA2) is an inhibitory type II C-type lectin expressed by human pDC. Here we determined the effects of BDCA2 internalisation on pDC mediated skin inflammation and fibrosis in human preclinical models of skin inflammation and fibrosis in vitro and in vivo. BDCA2 targeting reversed TLR-signalling induced transcriptome and differentiation of pDC and suppressed their ability to induce IFN response in organotypic 3D human skin cultures in vitro. In vivo, xenotransplantation of human pDC into immunocompromised mice (XenoSCID) significantly increased IFN induced responses to topical TLR7/9 agonist and separately enhanced the fibrotic response to bleomycin. Targeting of BDCA2 strongly suppressed both of these pathological responses ameliorating skin inflammation and fibrosis. Together, these preclinical data strongly support the notion that human pDC play a key role in immune driven skin fibrosis, which can be effectively blocked by targeting BDCA2.
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Dysregulated RASGRP1 expression through RUNX1 mediated transcription promotes autoimmunity 93%
- Follicular helper T cell signature of replicative exhaustion, apoptosis and senescence in common variable immunodeficiency 92%
- Maturation signatures of conventional dendritic cell subtypes in COVID-19 reflect direct viral sensing 92%
Similar papers in this journal
- Inhibition of histone readers bromodomain extra-terminal proteins alleviates skin fibrosis in experimental models of scleroderma 94%
- ERK hyperactivation in epidermal keratinocytes impairs intercellular adhesion and drives Grover disease pathology 93%
- Rapamycin rescues loss-of-function in blood-brain barrier-interacting regulatory T cells 93%
Similar papers in this journal
- The Beta secretase BACE1 drives fibroblasts activation in Systemic Sclerosis through the APP/Beta-catenin/Notch signalling axis 94%
- Mucosal associated invariant T cells are altered in patients with Hidradenitis Suppurativa and contribute to the inflammatory milieu 94%
- Stiffness-dependent LOX regulation via HIF-1 drives extracellular matrix modifications in psoriasis 94%
Similar papers in this journal
- Nuclear receptor subfamily 4A signaling as a key disease pathway of CD1c+ dendritic cell dysregulation in systemic sclerosis 96%
- Systemic Sclerosis dermal fibroblast exosomes trigger a Type 1 interferon response in keratinocytes through the TBK/JAK/STAT signalling axis 95%
- A Novel human IL-23A Overexpressing Mouse Model of Systemic Lupus Erythematosus 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.